Medical/Pharmaceuticals
ZEISS announces successful early implantations of the AT LUCIA toric 721P intraocular lens
The new intraocular lens combines an aspheric bitoric optic with a patented non-constant aberration design (ZO optic) on a fully preloaded, hydrophobic c-Loop platform to help deliver excellent visual outcomes and long-term stability for patients. JENA, Germany, June 11, 2026 /PRNewswire/ -- ZEI...
2026-06-11 19:00
4550
Cynosure Lutronic's XERF™, Worldwide Adoption Accelerates, Now 3x Faster
Now among the fastest-scaling monopolar RF devices worldwide, XERF™ has more than tripled its pace of adoption in recent months with Asia-Pacific and North America leading the surge. SINGAPORE, June 11, 2026 /PRNewswire/ -- Cynosure Lutronic's XERF™, the world's first multifrequency monopolar R...
2026-06-11 14:39
4487
Pantai Hospital Kuala Lumpur Launches AI-Powered Adaptive Radiotherapy System to Advance Personalised Cancer Care in Malaysia
Varian Ethos with HyperSight supports daily treatment adaptation, helping clinicians deliver more precise radiotherapy while reducing unnecessary exposure to healthy tissue KUALA LUMPUR, Malaysia, June 10, 2026 /PRNewswire/ -- Pantai Hospital Kuala Lumpur, part of the IHH Healthcare multination...
2026-06-11 08:41
5444
Frost & Sullivan: Global Pharmaceutical Industry Faces a High-Stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031
New Frost & Sullivan analysis reveals that future winners will be those that can execute faster, industrialise innovation, and navigate mounting pricing and geopolitical pressures LONDON, June 11, 2026 /PRNewswire/ -- Frost & Sullivan's latest analysis, Growth Opportunities in Global Pharmaceuti...
2026-06-11 04:56
3643
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting
Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board BOSTON and ROLLE, Switzerland, June 10, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medic...
2026-06-10 20:00
3799
Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders
* Partnership will combine n-Lorem's cutting-edge antisense oligonucleotide (ASO) technology and Servier's R&D expertise with the aim of advancing ASO technology and delivering precision medicine approaches for patients across the world. * Servier strengthens its commitment to rare neurologic...
2026-06-10 16:00
4147
Carestream Launches NEW Lux HD 35 and Lux HD 43 Detectors for Medical Imaging
SHANGHAI, June 10, 2026 /PRNewswire/ -- Carestream announces the availability of its new generation of Cesium Iodide (CsI), glass-free X-ray Detector in markets all over the world, the Carestream Lux HD 35 and Lux HD 43 Detectors. Carestream NEW Lux HD 35 and Lux HD 43 Detectors The Lux HD 35 ...
2026-06-10 10:30
4293
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
BOSTON and SHENZHEN, China, June 10, 2026 /PRNewswire/ -- XtalPi (2228.HK), a leading platform in artificial intelligence (AI) and robotics-driven drug discovery, today announced a strategic partnership with a prominent international biopharmaceutical company. The collaboration focuses on develo...
2026-06-10 10:00
5459
Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China
SHANGHAI and HONG KONG, June 10, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune di...
2026-06-10 09:00
5680
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
HANGZHOU, China, SHANGHAI and BOSTON, June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseases, today announced a significant clinical milestone achieved by its globa...
2026-06-10 08:00
3689
Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378
* COPD study initiation expands SKB378/WIN378 development into a second major respiratory disease * SKB378/WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase 2 data expected in the second half of 2026 * SKB378/WIN378 has the potential to be the firs...
2026-06-09 20:18
6182
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis
* Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. * Unique whole-cell design eliminates cell teardown, reducing sample preparation time by >90%. * Industry-leading Coin Cell DSC temperature range from –80...
2026-06-09 20:00
3592
Renowned Urologist Dr. (Col) Rajeev Sood joins Manipal Hospital Gurugram to strengthen Comprehensive Urology and Kidney Transplant services
GURUGRAM, India, June 9, 2026 /PRNewswire/ -- Manipal Hospital Gurugram, one of India's leading multi-specialty healthcare institutions, has further strengthened its Department of Urology, Robotics & Renal Transplant with the onboarding ofDr. (Col) Rajeev Sood, Chairman – Urology, Robotics & Rena...
2026-06-09 14:41
3787
GEHPA-APAC Alliance Officially Launched to Advance Inclusive & Intelligent Education and Healthcare
SHENZHEN, China, June 9, 2026 /PRNewswire/ -- Under the theme "Together, Advancing Inclusive & Intelligent Education and Healthcare," Huawei successfully hosted theHuawei APAC Education & Healthcare Partners Summit 2026 on June 5 as part of the 2026 Global Education & Healthcare Partners China C...
2026-06-09 14:06
4640
Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel
SHANGHAI, June 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an exclusive ...
2026-06-09 08:21
5715
THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE
Backed by direct scientific research with elite collegiate and youth athletes, CryoTherm Palm's cooling technology made its debut with the England national team supporting training camps, pre-tournament friendlies, and sideline recovery protocols LOS ANGELES, June 8, 2026 /PRNewswire/ -- Therabo...
2026-06-08 20:05
5888
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
* Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks. * Delivers up to 2x increase in resolving power and sensitivity to identify and track low-level impurities for improved regulatory read...
2026-06-08 20:00
4370
Classico Pokemon Collection: "Stay with Your Favorite Pokemon Everywhere"
TOKYO, June 8, 2026 /PRNewswire/ -- Classico, Inc., a Japanese medical apparel brand headquartered in Tokyo, launched the highly anticipated #ClassicoPokemonCollection across the Asian region, including Singapore, Malaysia, the Philippines, Hong Kong SAR, Taiwan region and Thailand, on June 4. F...
2026-06-08 14:00
3564
Dong Bang Co Ltd Strengthens Global Competitiveness with Advanced Veterinary Pharmaceuticals
SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dong Bang Co Ltd is strengthening its position in the global veterinary pharmaceutical market with high-value products including pet anesthetics and livestock reproductive hormones. Since its establishment in 1983, the company has specialized in m...
2026-06-08 13:00
3435
Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)
SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positive topline results from its Phase II randomized, double-blind, placebo-controlled trial of CG2001 ...
2026-06-08 09:28
5249
Week's Top Stories
Most Reposted
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 309 media titles]
2026-07-30 10:45
Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
[Picked up by 295 media titles]
2026-08-04 07:00
J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 294 media titles]
2026-07-30 15:00Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition
[Picked up by 290 media titles]
2026-08-04 14:30
Most Read
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
2026-07-30 10:45
17451
